Dr. Aaron E. Lisberg, MD

Dr. Lisberg practices at UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health.

Dr. Lisberg's NPI, 1043509797, was assigned on April 4, 2011. Dr. Lisberg graduated from University Of Minnesota Medical School in 2011. Dr. Lisberg's California license number on file is A131055.

Dr. Lisberg's primary practice is UCLA Santa Monica Medical Center, at 1250 16th Street, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 319-4000.

Dr. Lisberg's primary practice is UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health. Dr. Lisberg is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Lisberg to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lisberg practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Lisberg's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lisberg is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Lisberg's licenses on file in 2 states: California and Washington.

Dmand AI lists colorectal cancer, lung cancer, lymphoma and prostate cancer among the conditions Dr. Lisberg treats.

CMS data shows 254 Medicare services from Dr. Lisberg across 4 procedure codes in 2024, for 68 Medicare patients. Medicare paid $15,406 for them. Every service was in an office.

CMS counts 68 Medicare patients who saw Dr. Lisberg in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have cancer, and 71% have high cholesterol. 25% are also on Medicaid. Their average risk score is 3.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lisberg's median patient age at 66, with 57% women.

In 2024, Dr. Lisberg wrote 105 Medicare Part D claims for 14 patients. 44% of them were for generic drugs. CMS names the drug for 59 of them, across 2 drugs with 11 or more claims each, at $629,212 in total drug cost. In 2023, CMS named 68 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Lisberg for performance year 2024, reported as part of a group. Dr. Lisberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lisberg as offering telehealth.

Dmand AI links 12 papers to Dr. Lisberg, published from 2002 to 2025. 2025 was the busiest year, with 4. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Antibodies, Monoclonal, Humanized. Dr. Lisberg has published most often in J Clin Oncol. Dr. Lisberg's most frequent co-authors are Jacob Magee Sands, MD, George R. Blumenschein, MD and Edward Brian Garon, MD.

CMS Open Payments shows 139 general payments to Dr. Lisberg from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 74% of the total. AstraZeneca Pharmaceuticals LP paid the most, $55,772.

Dr. Lisberg graduated from University Of Minnesota Medical School in 2011.

Dr. Lisberg is in network with 13 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.